Search filters

Filters

Clear All

Phase

  • 6
  • 2
  • 5
  • 5
  • 1
  • 13
  • 36
  • 21
  • 2
  • 10
  • 24

Found 36 Pregnancy trials

A listing of Pregnancy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A PHASE IV MULTICENTER OPEN-LABEL STUDY EVALUATING B CELL LEVELS IN INFANTS POTENTIALLY EXPOSED TO OCRELIZUMAB DURING PREGNANCY - THE MINORE STUDY

All genders
This study will evaluate the potential placental transfer of ocrelizumab in women with clinically isolated syndrome (CIS) or multiple sclerosis (MS) [in line with the locally approved indications] whose last dose of ocrelizumab was administered any time from 6 months before the last menstrual period (LMP) through to the first …
 The Diaphragmatic Initiated Ventilatory Assist (Diva) Trial

The Diaphragmatic Initiated Ventilatory Assist (Diva) Trial

All genders
Interventional
DIVA is a pragmatic randomized clinical trial (RCT) to determine: among (P) preterm infants born 24-27 6/7 weeks gestation undergoing extubation from mechanical ventilation, whether (I) Non-invasive neurally adjusted ventilatory assist (NIV-NAVA) (C) compared with Non-synchronized nasal intermittent positive pressure ventilation (NS-NIPPV), will reduce the incidence of (O) extubation failure …
 CCN013C

CCN013C

18 years - 40 years
Accepts healthy volunteer
Female
Phase 2
Some research studies have shown that morning-after pills containing LNG do not work as well in preventing pregnancy for women who weigh more than 80kg (176 pounds) and that doubling the dose of LNG would offer greater protection against pregnancy for these women. This study is being done to test …

Study to Evaluate LevoCept, a Long-Acting Reversible Intrauterine System, for Contraceptive Efficacy Safety and Tolerability.

All genders
Phase 3
Interventional
The primary objective of the study is to assess the contraceptive efficacy (prevention of pregnancy) of LevoCept. The secondary objectives of the study are to assess the following for LevoCept: Safety and tolerability; Return to fertility after LevoCept removal, only for subjects requesting LevoCept removal to become pregnant; Release rate …

A Phase 2 Multicenter Randomized Double-Blind Placebo-Controlled Parallel Group Trial to Investigate the Efficacy and Safety of Daxdilimab Subcutaneous Injection in Reducing Disease Activity in Adult Participants with Moderate-to-Severe Primary Discoid Lupus Erythematosus

All genders
Phase 2
PURPOSE: Phase 2 study to evaluate effect of daxdilimab vs placebo to reduce DLE activity in adults 18-75 yo with DLE. 60 wks 99 pts multiple sites 3 trx grps: placebo; daxdilimab 150 mg; daxdilimab 300 mg. Randomize 1:1:1 sc injections q 4 wks Screening--4 wks; Treatment--48 wks; Follow-Up--8 wks. …

403 trial 11w

All genders
Participants will be asked to provide biological samples at different time points during your pregnancy and delivery of your baby.    These samples may be collected when you are getting other clinical tests done or you may be asked to have your blood drawn utilizing a drive up location or …
 Propranolol Rescue of Prolonged Labor

Propranolol Rescue of Prolonged Labor

18 years - 99 years
All genders
Phase 4
Over 30% of all cesarean deliveries (CD) performed in the United States are for prolonged labor. Current management strategies to resolve prolonged labor fail up to 50% of the time. The uterus is known to express beta receptors, which when stimulated, cause uterine relaxation. Accordingly, beta blockade has been shown …

Study of preconception food security glycemia and nutrition

18 years - 40 years
Female
This research study is being conducted to determine if diet quality and blood glucose levels in women trying to achieve pregnancy are affected by food insecurity and other social stressors If you agree to participate in the study, you will be asked to complete the following research procedures: collection of …

Test STudy67

Male
-For US: Aged 10 to 25 years on the day of inclusion ("10-25 years" means from the day of the 10th birthday to the day before the 26th birthday) For EU: Aged 42 to 89 days or 12 to 18 months or 10 to 50 years on the day of …
 Phase 2 Trial of AGEN2034 (anti-PD-1) as a Monotherapy of Combination Therapy with AGEN1884 (anti-CTLA4) or with Placebo in Women with Recurrent Cervical Cancer (Second Line) - RaPiDS

Phase 2 Trial of AGEN2034 (anti-PD-1) as a Monotherapy of Combination Therapy with AGEN1884 (anti-CTLA4) or with Placebo in Women with Recurrent Cervical Cancer (Second Line) - RaPiDS

All genders
Phase 2
The research study is being conducted to study the PD-1 antibody, AGEN2034 alone, or in combination with the CTLA-4 antibody, AGEN1884, in women with recurrent cervical cancer. Subjects will be asked to complete the following research procedures: 12 lead electrocardiogram (ECG) and evaluation of heart function (to determine heart health). …
11 - 20 of 36